搜索临床试验以:BOTULINUM TOXIN
总计1519个结果
-
Balgrist University HospitalSwiss National Science Foundation完全的
-
Yale UniversityMerz North America, Inc.完全的
-
National Taiwan University HospitalChina Medical University Hospital; Chang Gung Memorial Hospital; Taipei Medical University Hospital 和其他合作者未知
-
Yale UniversityMerz North America, Inc.终止
-
Pfizer完全的
-
National University Hospital, SingaporeNational University of Singapore完全的
-
Hospital Universitario Reina Sofia de Cordoba完全的
-
INSYS Therapeutics Inc完全的
-
INSYS Therapeutics IncPediatric Brain Tumor Consortium (PBTC), St. Jude Children's Research Hospital撤销
-
The Children's InstituteDuquesne University; Health Resources and Services Administration (HRSA)完全的
-
Cady, Roger, M.D.GlaxoSmithKline完全的
-
National University Hospital, SingaporeNational University of Singapore未知
-
Technical University of KenyaUniversity of Western Ontario, Canada未知
-
Western University, CanadaNational Institute for Medical Research, Tanzania完全的
-
National Cancer Institute (NCI)完全的复发性成人急性髓性白血病 | 骨髓增生异常综合征后伴多系发育不良的急性髓系白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 继发性急性髓性白血病 | 成人急性早幼粒细胞白血病 (M3) | 先前治疗过的骨髓增生异常综合征 | 复发性成人急性淋巴细胞白血病 | 复发性慢性粒细胞白血病 | 继发性骨髓增生异常综合征 | 成人急性髓性白血病伴 t(15;17)(q22;q12) | 骨髓增生异常/骨髓增生性肿瘤,无法分类 | 急变期慢性粒细胞白血病美国
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical Corporation完全的
-
Alexion Pharmaceuticals完全的
-
University Hospital, Bordeaux完全的
-
DynPort Vaccine Company LLC, A GDIT Company完全的
-
Asan Medical CenterSamsung Medical Center; Seoul St. Mary's Hospital; Korea University Guro Hospital; Gangnam Severance... 和其他合作者完全的
-
M.D. Anderson Cancer CenterWake Forest University终止
-
Novartis Vaccines完全的
-
Centre Hospitalier du Centre du ValaisUniversity of Lausanne Hospitals; Research Unit CHCVs Hôpital de Sion Switzerland; Immunology...未知
-
University Hospital, GhentGambro Corporate Research, Sweden完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center完全的
-
INSYS Therapeutics Inc完全的